Ultra Low Doses of Rituximab in RA: Dr. Eric Dein and Nathan den Broeder Save
In this interview, panelists discuss abstract #1443 presented at the ACR21 annual meeting.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.